Skip to main content
. Author manuscript; available in PMC: 2019 Apr 15.
Published in final edited form as: J Immunol. 2018 Mar 5;200(8):2727–2737. doi: 10.4049/jimmunol.1701764

Table I.

Details of 49 proteins selected for in silico analysis of epitope binding affinity predictions using NetMHCIIpan2.1

Protein name Product GeneDB/GenBank Accession Reference
A2 LINJ220670 hypothetical protein UniProtKB - A4HZU7_LEIIN (34)
CPL2 cathepsin L-like protease LdBPK_080960.1 (35)
CPA/CBA cysteine peptidase A LdBPK_191460.1 (36)
CPB cysteine peptidase B LdBPK_070600.1 (36)
CPC cysteine peptidase C LdBPK_290860.1 (37)
gp46/PSA/M-2 surface membrane protein gp46 LdBPK_311490.1 (38)
gp63/MSP GP63, leishmanolysin GenBank: ACT31401.1 (39)
HASPB1/K26 hydrophilic acylated surface protein B GenBank: CAA09789.1 (40)
HbR hemoglobin receptor LdBPK_210300.1; (41)
Hsp70 HSP70-like protein LdBPK_283000.1 (39)
J41 hypothetical protein LdBPK_331620.1 (42)
J89 hypothetical protein LdBPK_260990.1 (42)
KMP11 kinetoplastid membrane prot-1 LdBPK_352260.1 (43)
L15 anaphase promoting complex subunit LdBPK_354570.1 (42)
L21 nucleolar protein family a member LdBPK_343810.1 (42)
lmd29 hypothetical protein LdBPK_180600.1 (42)
L302.06 hypothetical protein, conserved LdBPK_040220.1 (42)
L31/584C 60S ribosomal subunit L31 LdBPK_353330.1 (42)
L37 60S ribosomal L37 LdBPK_342620.1 (42)
L5 60S ribosomal L5 LdBPK_351870.1 (44)
L3 ribosomal protein L3-like LdBPK_323320.1 (44)
LACK/p36 activated protein kinase c receptor LdBPK_282970.1 (45)
LeIF eukaryotic initiation factor 4a LdBPK_010790.1 (46)
Lepp12 phosphoprotein lepp12 LdBPK_365970.1 (47)
LmSTI1 stress-induced protein sti1 LdBPK_081020.1 (48)
LPG3 lipophosphoglycan biosynthetic LdBPK_290790.1 (49)
M18 amastin-like protein LdBPK_080720.1 (42)
N52 vacuolar ATP synthase subunit LdBPK_120480.1 (42)
NH36 nonspecific nucleoside hydrolase LdBPK_181570.1 (50)
PABP1 polyadenylate-binding protein 1 LdBPK_355360.1 (51)
PABP2 polyadenylate-binding protein 2 LdBPK_354200.1 (51)
PABP3 poly(A)-binding protein, putative LdBPK_250080.1 (51)
Pxn4 peroxidoxin_4 LdBPK_230050.1 (52)
PO 60S acidic ribosomal protein P0 LdBPK_072480.1 (53)
P25 hypothetical protein LdBPK_354800.1 (42)
P31 hypothetical protein, conserved LdBPK_342300.1 (42)
PRP-2 paraflagellar rod protein 2C LdBPK_161510.1 (54)
Q24 dynein light chain, flagellar outer arm LdBPK_320240.1 (42)
Q51 hypothetical protein LdBPK_301750.1 (42)
R32 hypothetical protein LdBPK_333110.1 (42)
R71 60S ribosomal protein L22 LdBPK_363430.1 (42)
S4 40S ribosomal protein S4 LdBPK_131120.1 (55)
S33 eukaryotic initiation factor 5a LdBPK_250740.1 (42)
SOD B1 iron superoxide dismutase LdBPK_321910.1 (56)
SMT sterol 24-c-methyltransferase LdBPK_362520.1 (57)
TSA/TRYP tryparedoxin peroxidase LdBPK_151140.1 (31)
TUZIN1 Tuzin, putative (62.3 kDa) LdBPK_342640.1 (58)
TUZIN2 Tuzin, putative (58.7 kDa) LdBPK_080730.1 (58)
TUZIN3 Tuzin, putative (70.2 kDa) LdBPK_080740.1 (58)

Except for A2, all protein sequences were based on L. donovani sequences, as represented in GeneDB or GenBank. References to vaccine candidacy are not comprehensive, especially where multiple studies have been undertaken. Where possible we quote a reference where pre-clinical vaccine studies were undertaken in a model of visceral leishmaniasis.